A Role for FDG-PET in the Surgical Management of Stage IV Melanoma Jeffrey D. Wagner EditorialNotes Pages: 721 - 722
MammoSite RTS: The Reporting of Initial Experiences and How to Interpret Douglas W. ArthurFrank A. Vicini EditorialNotes Pages: 723 - 724
Sentinel Lymph Node Biopsy For Early Stage Clinical N0 Squamous Cell Carcinoma of the Oral Cavity Thom R. Loree EditorialNotes Pages: 725 - 726
Is it Time to Change Surgical Strategy for Gastric Cancer in the United States? Angelos M. KappasMichael FatourosDimitrios H. Roukos EditorialNotes Pages: 727 - 730
A Prospective Analysis of Positron Emission Tomography and Conventional Imaging for Detection of Stage IV Metastatic Melanoma in Patients Undergoing Metastasectomy Steven E. FinkelsteinJorge A. CarrasquilloRichard M. Sherry Original Articles Pages: 731 - 738
Acute Toxicity of High-Dose-Rate Intracavitary Brachytherapy With the MammoSite Applicator in Patients With Early-Stage Breast Cancer Gregory M. RichardsAnthony M. BersonChristopher Mills Original Articles Pages: 739 - 746
Comparison of Frozen Section and Touch Imprint Cytology for Evaluation of Sentinel Lymph Node Metastasis in Breast Cancer Tomohiko AiharaSatoru MunakataYuichi Takatsuka Original Articles Pages: 747 - 750
Male Breast Cancer: Is the Incidence Increasing? Nicole C. F. HodgsonJaclyn H. ButtonAlan S. Livingstone Original Articles Pages: 751 - 755
Preoperative Magnetic Resonance Imaging Evaluation for Breast Cancers After Sonographically Guided Core-Needle Biopsy: A Comparison Study Yun-Chung CheungYung-Liang WanSwei Hsueh Original Articles Pages: 756 - 761
Determinants of Patients’ Choice of Reconstruction with Mastectomy for Primary Breast Cancer P. AnanianG. HouvenaeghelC. Julian-Reynier Original Articles Pages: 762 - 771
Validation of Ex Vivo Lymphatic Mapping in Hematoxylin-Eosin Node-Negative Carcinoma of the Colon and Rectum Jan H. WongD.Scott JohnsonPamela Tauchi-Nishi Original Articles Pages: 772 - 777
Rapid Genetic Diagnosis With the Transcription—Reverse Transcription Concerted Reaction System for Cancer Micrometastasis Takaaki IshiiYoshiyuki FujiwaraMorito Monden Original Articles Pages: 778 - 785
Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid Cancer J. W. B. de GrootTh. P. LinksJ. Th. M. Plukker Original Articles Pages: 786 - 794